← Leaderboards
Chinazo Cunningham
Albert Einstein College Of Medicine
$8,282,391
Attributed
$9,257,378
Total exposure
6
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.7M · FY2011–19$2M$1.5M$1M$500K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$7,794,898 · 5
AHRQ$1,462,480 · 1
By mechanism
R01$6,008,699 · 2
K12$1,462,480 · 1
K24$910,537 · 1
R34$708,662 · 1
R03$167,000 · 1
Top collaborators
- Paul R Marantz2 shared
- Michael L Rinke2 shared
Most similar at Albert Einstein College Of Medicine
Same institution · by research overlap
- Aaron D Fox$6,420,892
- Nina Cooperman$7,023,812
- Joanna L. Starrels$10,126,099
- Benjamin T Hayes$777,083
- Shadi Nahvi$5,215,866
Others in their field
Top investigators on “Opioid”
- Chanza Baytop · Westat, Inc.$271,217,917
- Wafaa M. El-Sadr · Columbia University Health Sciences$101,800,876
- Myron S Cohen · Family Health International$101,800,876
- Sharon L. Walsh · University Of Kentucky$96,444,120
- Jeffrey H Samet · Boston University Medical Campus$95,014,310
- Edward V Nunes · Columbia University Health Sciences$85,118,880
Research focus
OpioidParticipantBaseQuestionnairesFundingViral Load ResultPharmaceutical PreparationsCocaineUrineCd4 Lymphocyte CountDrug UsageCocaine UsePrimary OutcomeDrug UserBehaviorTreatment OutcomeContingency ManagementAbstinenceEnrollmentUnited States National Institutes Of HealthAgonistEfficacy TestingBlood TestsHiv Infections
Grant awards (25)
Does medical cannabis reduce opioid analgesics in HIV+ and HIV- adults with pain?$769,238
R01 · FY2019 · DA · contact PI
The Center of Excellence in Promoting LHS Operations and Research at Einstein/Montefiore (EXPLORE)$731,240
K12 · FY2019 · HS
Mentoring researchers on drug abuse and HIV$167,241
K24 · FY2019 · DA · contact PI
The Center of Excellence in Promoting LHS Operations and Research at Einstein/Montefiore (EXPLORE)$731,240
K12 · FY2018 · HS
Does medical cannabis reduce opioid analgesics in HIV+ and HIV- adults with pain?$578,577
R01 · FY2018 · DA · contact PI
Does medical cannabis reduce opioid analgesics in HIV+ and HIV- adults with pain?$210,377
R01 · FY2018 · DA · contact PI
Does medical cannabis reduce opioid analgesics in HIV+ and HIV- adults with pain?$802,762
R01 · FY2017 · DA · contact PI
Mentoring researchers on drug abuse and HIV$137,339
K24 · FY2017 · DA · contact PI
Resilience in HIV infected drug users$83,261
R03 · FY2017 · DA · contact PI
Mentoring researchers on drug abuse and HIV$48,485
K24 · FY2017 · DA · contact PI
Resilience in HIV infected drug users$239
R03 · FY2017 · DA · contact PI
Mentoring researchers on drug abuse and HIV$185,824
K24 · FY2016 · DA · contact PI
Resilience in HIV infected drug users$83,500
R03 · FY2016 · DA · contact PI
Abstinence Reinforcing Contingency Management to Suppress HIV Viral Load$458,462
R01 · FY2015 · DA · contact PI
Abstinence Reinforcing Contingency Management to Suppress HIV Viral Load$229,231
R01 · FY2015 · DA · contact PI
Mentoring researchers on drug abuse and HIV$108,397
K24 · FY2015 · DA · contact PI
Mentoring researchers on drug abuse and HIV$77,427
K24 · FY2015 · DA · contact PI
Abstinence Reinforcing Contingency Management to Suppress HIV Viral Load$715,981
R01 · FY2014 · DA · contact PI
Mentoring researchers on drug abuse and HIV$185,824
K24 · FY2014 · DA · contact PI
Abstinence Reinforcing Contingency Management to Suppress HIV Viral Load$705,411
R01 · FY2013 · DA · contact PI
Development of a community-based buprenorphine treatment intervention$207,994
R34 · FY2013 · DA · contact PI
Abstinence Reinforcing Contingency Management to Suppress HIV Viral Load$753,297
R01 · FY2012 · DA · contact PI
Development of a community-based buprenorphine treatment intervention$277,272
R34 · FY2012 · DA · contact PI
Abstinence Reinforcing Contingency Management to Suppress HIV Viral Load$785,363
R01 · FY2011 · DA · contact PI
Development of a community-based buprenorphine treatment intervention$223,396
R34 · FY2011 · DA · contact PI